12 killed as lorry ploughs into Berlin Xmas market

December 20, 2016

Berlin, Dec 20: A lorry ploughed into a busy Christmas market in Berlin, killing at least 12 people and injuring dozens more in what police said was a suspected terror attack.

Xmasmarket

Ambulances and heavily armed police rushed to the area yesterday after the vehicle mounted the pavement of the market in a square popular with tourists, in horrific scenes reminiscent of July's deadly truck attack in the French Riviera city of Nice.

"I don't want to use the word 'attack' yet, although there are many things pointing to one," Interior Minister Thomas de Maiziere told public television.

As witnesses described scenes of panic and carnage, police said at least 12 people were killed and 48 others were injured in the incident which comes less than a week before Christmas.

Australian Trisha O'Neill told the Australian Broadcasting Corporation she was only metres from where the truck smashed into the crowded market.

"I just saw this huge black truck speeding through the markets crushing so many people and then all the lights went out and everything was destroyed.

"I could hear screaming and then we all froze. Then suddenly people started to move and lift all the wreckage off people, trying to help whoever was there."

O'Neill said there was "blood and bodies everywhere".

A German police spokeswoman told AFP that a man who was apparently driving the truck had been detained while the passenger was dead.

Security sources cited by DPA news agency said that the man behind the wheel was an asylum seeker from Afghanistan or Pakistan who arrived in Germany in February.

The daily Tagesspiegel said the man was known to police but for minor crimes, not links to terrorism.

The Polish owner of the lorry confirmed his driver was missing.

"We haven't heard from him since this afternoon. We don't know what happened to him. He's my cousin, I've known him since I was a kid. I can vouch for him," transport company owner Ariel Zurawski told AFP.

German authorities said there was no indication of "further dangerous situations in the city near Breitscheidplatz", where the suspected attack took place.

"We are investigating whether it was a terror attack but do not yet know what was behind it," a police spokesman said.

Chancellor Angela Merkel reacted quickly to the tragedy, with spokesman Steffen Seibert tweeting: "We mourn the dead and hope that the many people injured can be helped."

Traditional Christmas markets are popular in cities and towns throughout Germany and have frequently been mentioned by security services as potentially vulnerable to attacks.

"It's awful. We were in Berlin for Christmas," said American tourist Kathy Forbes. "We also thought it would be safer than Paris."

The crash happened in the shadow of the Kaiser Wilhelm Memorial Church whose damage in a World War II bombing raid has been preserved as a warning to future generations.

The square is at the end of the Kurfuerstendamm boulevard which was packed with holiday shoppers.

Police said the truck made it as far as 80 metres into the Christmas market before it came to a halt.

Europe has been on high alert for most of 2016, with terror attacks striking Paris and Brussels, while Germany has been hit by several assaults claimed by the Islamic State group and carried out by asylum-seekers.

An axe rampage on a train in the southern state of Bavaria in July injured five people, and a suicide bombing wounded 15 people in the same state six days later.

In another case, a 16-year-old German-Moroccan girl in February stabbed a police officer in the neck with a kitchen knife, wounding him badly, allegedly on IS orders.

The arrival of 890,000 refugees last year has polarised Germany, with critics calling the influx a serious security threat.

The attack in Berlin also comes five months after Tunisian extremist Mohamed Lahouaiej Bouhlel ploughed a 19-tonne truck into a crowd on the Nice seafront, killing 86 people.

In response to the Berlin tragedy, France beefed up security at its own Christmas markets.

"The French share in the mourning of the Germans in the face of this tragedy that has hit all of Europe," President Francois Hollande said.

The Nice bloodshed -- as people were watching a fireworks display on the Bastille Day holiday on July 14 -- further traumatised a France already reeling from a series of jihadist attacks.

The United States labelled it an apparent "terrorist attack" and pledged its support.

President-elect Donald Trump blamed "Islamist terrorists" for a "slaughter" of Christians in the German capital.

Comments

ibbu
 - 
Wednesday, 21 Dec 2016

12 people died and all monkeys opened their mouths now..... every minutes 100 children, ladies and gents are dieing in syria and all bloody mouths are shuts.... shits in their mouths.....
all news channel are bsy with 12 people.....

Naren kotian
 - 
Tuesday, 20 Dec 2016

What else we can accept from third rated community ...German people showed big heart and let in millions ..but these people are back stabbing ...jathi buddhi yelli hogathe

Bopanna
 - 
Tuesday, 20 Dec 2016

No islam = Know Peace
Know Islam = No Peace

The minute I heard the news I knew it will be a follower of the religion of Piss driving this truck ....

What can you expect from the follower of a paedophile ?

Sadi
 - 
Tuesday, 20 Dec 2016

THis will be headlines and what about Syrians, Iraqis, Afghani and Gazans dying every minutes due to bombing by western forces and Israelis??? Only Berlin people, Israelis, French, US people have lives???

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 15,2020

May 15: Global deaths linked to the novel coronavirus passed 300,000 on Thursday, while reported cases of the virus are approaching 4.5 million, according to a news agency tally.

About half of the fatalities have been reported by the United States, the United Kingdom and Italy.

The first death linked to the disease was reported on January 10 in Wuhan, China. It took 91 days for the death toll to pass 100,000 and a further 16 days to reach 200,000, according to the Reuters tally of official reports from governments. It took 19 days to go from 200,000 to 300,000 deaths.

By comparison, an estimated 400,000 people die annually from malaria, one of the world’s most deadly infectious diseases.

The United States had reported more than 85,000 deaths from the new coronavirus, while the United Kingdom and Italy have reported over 30,000 fatalities each.

While the current trajectory of COVID-19 falls far short of the 1918 Spanish flu, which infected an estimated 500 million people, killing at least 10% of patients, public health experts worry the available data is underplaying the true impact of the pandemic.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Tokyo, Mar 4: Takeda Pharmaceutical Co said on Wednesday it was developing a drug to treat COVID-19, the flu-like illness that has struck more than 90,000 people worldwide and killed over 3,000.

The Japanese drugmaker is working on a plasma-derived therapy to treat high-risk individuals infected with the new coronavirus and will share its plans with members of the U.S. Congress on Wednesday, it said in a statement.

Takeda is also studying whether its currently marketed and pipeline products may be effective treatments for infected patients.

"We will do all that we can to address the novel coronavirus threat...(and) are hopeful that we can expand the treatment options," Rajeev Venkayya, president of Takeda's vaccine business, said in the statement.

Takeda said it was in talks with various health and regulatory agencies and healthcare partners in the United States, Asia and Europe to move forward its research into the drug.

Its research requires access to the blood of people who have recovered from the respiratory disease or who have been vaccinated, once a vaccine is developed, Takeda said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 10,2020

Melbourne, Apr 10: Scientists have identified six drug candidates from more than 10,000 compounds that may help treat COVID-19.

The research, published in the journal Nature, tested the efficacy of approved drugs, drug candidates in clinical trials and other compounds.

"Currently there are no targeted therapeutics or effective treatment options for COVID-19," said Professor Luke Guddat from the University of Queensland in Australia.

"In order to rapidly discover lead compounds for clinical use, we initiated a programme of high-throughput drug screening, both in laboratories and also using the latest computer software to predict how different drugs bind to the virus," Guddat said.

The project targeted the main COVID-19 virus enzyme, known as the main protease or Mpro, which plays a pivotal role in mediating viral replication, the researchers said.

This makes it an attractive drug target for this virus, and as people don't naturally have this enzyme, compounds that target it are likely to have low toxicity, they said.

"We add the drugs directly to the enzyme or to cell cultures growing the virus and assess how much of each compound is required to stop the enzyme from working or to kill the virus. If the amount is small, then we have a promising compound for further studies," said Guddat.

After assaying thousands of drugs, researchers found of the six that appear to be effective in inhibiting the enzyme, one is of particular interest.

"We're particularly looking at several leads that have been subjected to clinical trials including for the prevention and treatment of various disorders such as cardiovascular diseases, arthritis, stroke, atherosclerosis and cancer," Guddat said.

Researchers said compounds that are already along the pipeline to drug discovery are preferred, as they can be further tested as antivirals at an accelerated rate compared to new drug leads that would have to go through this process from scratch.

"With continued and up-scaled efforts we are optimistic that new candidates can enter the COVID-19 drug discovery pipeline in the near future," Guddat said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.